Predicting mRNA degradation to improve vaccine stability

Image source: Adobe Stock/REDPIXEL 

News • Vaccination

Predicting mRNA degradation to improve vaccine stability

Messenger Ribonucleic Acid (mRNA) as a therapeutic approach is gaining momentum due to its ability to be rapidly manufactured and its promising outcomes.

mRNA-based vaccines, for instance, played a crucial role in the fight against COVID-19 in many parts of the world. However, mRNA-based therapeutics can face challenges due to their thermal instability, which makes them susceptible to chemical degradation. As a result, mRNA vaccines require stringent conditions for manufacturing, storage and worldwide delivery. To make mRNA vaccines more broadly accessible, it is critical to understand and improve their stability. 

Dr. Qing Sun, a professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, and a team of graduate students have created an effective and interpretable model architecture using deep-learning techniques that can predict RNA degradation more accurately than previous best methods, such as Degscore models, RNA folding algorithms and other machine-learning models. Their model was tested to show its efficiency, and the findings were recently published in Briefings in Bioinformatics

"mRNA's inherent thermal instability has hampered the distribution of mRNA vaccines worldwide due to in-line hydrolysis, a chemical degradation reaction," said Sun. "For this reason, our research seeks to understand and predict mRNA degradations." To combat this problem, Sun and her team turned to deep-learning techniques, in which they developed the RNAdegformer - a deep-learning-based model powered by artificial neural networks capable of extracting data and using these insights to make predictions. 

According to Sun, the RNAdegformer processes RNA sequences with self-attention and convolutions, two deep-learning techniques that have proved dominant in the fields of computer vision and natural language processing while utilizing the biophysical features of RNA secondary structure features and base pairing probabilities. "The RNAdegformer outperforms previous best methods at predicting degradation properties at the nucleotide level, which are like letters of a sentence that combine to form mRNA," said Sun. "We can make predictions about each nucleotide in COVID-19 mRNA vaccines. RNAdegformer predictions also exhibit improved correlation with RNA in vitro half-life compared with previous best methods."

With our research, we hope we will be able to design more stable mRNA vaccines using our model to allow more equity and more broad usage of mRNA therapeutics

Dr. Qing Sun

Additionally, the research shows how direct visualization of self-attention maps assists informed decision-making. According to Shujun He, a graduate student in Sun's group and the paper's first author, attention maps show how the model "thinks" using input information, which assists in informed decision-making based on model predictions. Further, their model reveals essential features in determining mRNA degradation rates. The team worked with Rhiju Das, an associate professor of biochemistry at Stanford University whose high-quality mRNA degradation data served as a starting point for this study. "With our research, we hope we will be able to design more stable mRNA vaccines using our model to allow more equity and more broad usage of mRNA therapeutics," said Sun.

Source: Texas A&M University College of Engineering 


Read all latest stories

Related articles


News • Sars-CoV-2 infection aftereffects

Diabetes after Covid-19: Researchers find possible connection

German researchers have now investigated whether there is a temporal association between infection with the Sars-CoV-2 virus and the development of type 1 diabetes.


News • AI milestone

ChatGPT-4 passes radiology board exam

The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large language models but also revealing limitations that hinder reliability, new research shows.


News • Promising biomarker found

Who will develop long Covid? It's in the blood

New research has found molecular signature differences in the blood of patients who fully recover from Covid-19 and those who develop long Covid.

Related products

Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon · Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
CT Image Reconstruction

Artificial Intelligence

Canon · CT Image Reconstruction

Canon Medical Systems Europe B.V.
CXDI Elite series

DR Detectors

Canon · CXDI Elite series

Canon Medical Components Europe B.V.
HIT Automation Platform

Artificial Intelligence

Canon · HIT Automation Platform

Canon Medical Systems Europe B.V.
Intelligent Noise Reduction (INR)

Accessories / Complementary Systems

Canon · Intelligent Noise Reduction (INR)

Canon Medical Components Europe B.V.
Subscribe to Newsletter